Table 1 Effects of feG on the binding of antibodies to cell adhesion and associated molecules in PAF-stimulated cells.
From: Modulation of neutrophil function by the tripeptide feG
Antibody | Isotype Control | Control | PAF | PAF & feG1 | % Change |
|---|---|---|---|---|---|
CD11a | 5.2 ± 0.62 | 27.7 ± 5.9 | 30.6 ± 4.5 | 34.6 ± 5.0 | +11 ± 33 |
CD11b | 4.2 ± 0.4 | 148.1 ± 12.8 | 291.6 ± 14.1# | 242.1 ± 16.3* | -17 ± 4 (-34)4 |
CD11c | 5.7 ± 0.2 | 38.2 ± 6.8 | 52.4 ± 7.3 | 47.9 ± 6.0 | -9 ± 5 |
CD14 | 5.8 ± 0.3 | 17.9 ± 1.8 | 33.7 ± 1.2# | 32.5 ± 1.8 | -4 ± 3 |
CD16b | 19.8 ± 2.9 | 357.4 ± 55.4 | 450.7 ± 62.5 | 297.9 ± 53.2* | -33 ± 7 (-164)4 |
CD18 | 4.6 ± 0.5 | 85.7 ± 3.5 | 95.6 ± 2.9 | 94.6 ± 2.1 | -1 ± 3 |
CD43 | 2.9 ± 0.2 | 48.5 ± 5.7 | 23.3 ± 3.2†| 22.4 ± 3.1 | -4 ± 2 |
CD62L | 4.5 ± 0.4 | 57.6 ± 4.8 | 27.1 ± 2.4†| 29.2 ± 2.5 | +8 ± 5 |
CD87 | 8.7 ± 1.9 | 40.7 ± 6.6 | 41.0 ± 3.0 | 44.1 ± 1.6 | +7 ± 4 |
CD162 | 51.0 ± 13.9 | 307.4 ± 40.0 | 222.7 ± 23.9 | 219.2 ± 46.4 | -2 ± 3 |